One major unmet clinical need in epilepsy is the identification of therapies to prevent or arrest epilepsy development in patients exposed to a potential epileptogenic insult. The development of such treatments has been hampered by the lack of non-invasive biomarkers that could be used to identify the patients at-risk, thereby allowing to design affordable clinical studies. Our goal was to test the predictive value of cognitive deficits and brain astrocyte activation for the development of epilepsy following a potential epileptogenic injury. We used a model of epilepsy induced by pilocarpine-evoked status epilepticus (SE) in 21-day old rats where 60-70% of animals develop spontaneous seizures after around 70 days, although SE is similar in all rats. Learning was evaluated in the Morris water-maze at days 15 and 65 post-SE, each time followed by proton magnetic resonance spectroscopy for measuring hippocampal myo-Inositol levels, a marker of astrocyte activation. Rats were video-EEG monitored for two weeks at seven months post-SE to detect spontaneous seizures, then brain histology was done. Behavioral and imaging data were retrospectively analysed in epileptic rats and compared with non-epileptic and control animals. Rats displayed spatial learning deficits within three weeks from SE. However, only epilepsy-prone rats showed accelerated forgetting and reduced learning rate compared to both rats not developing epilepsy and controls. These deficits were associated with reduced hippocampal neurogenesis. myo-Inositol levels increased transiently in the hippocampus of SE-rats not developing epilepsy while this increase persisted until spontaneous seizures onset in epilepsy-prone rats, being associated with a local increase in S100β-positive astrocytes. Neuronal cell loss was similar in all SE-rats. Our data show that behavioral deficits, together with a non-invasive marker of astrocyte activation, predict which rats develop epilepsy after an acute injury. These measures have potential clinical relevance for identifying individuals at-risk for developing epilepsy following exposure to epileptogenic insults, and consequently, for designing adequately powered antiepileptogenesis trials.
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Introduction
Epileptogenesis is a dynamic process of molecular, cellular and functional reorganization occurring in brain following precipitating events that lead to epilepsy (Pitkanen and Engel, 2014) . Epilepsy is one of the most prevalent brain disorders affecting around 60 million people worldwide (Duncan et al., 2006) . It is characterized by an enduring predisposition to generate spontaneous seizures often associated with cognitive and psychiatric comorbidities with negative social consequences. One major clinical need in epilepsy is to identify antiepileptogenesis treatments for preventing or arresting the development of the disease in patients who have been exposed to potentially epileptogenic brain insults, including status epilepticus (SE) (Holtkamp et al., 2005; Wagenman et al., 2014) . The development of such treatments has been hampered by the lack of non-invasive biomarkers that could be used to identify the patients at-risk, thereby allowing to design affordable clinical studies (Engel et al., 2013; Pitkanen and Engel, 2014) .
Our main goal was to test if cognitive deficits and astrocyte activation in seizure susceptible brain areas, both phenomena occurring in human epilepsy (Elger et al., 2004; Vezzani et al., 2012) and related animal models (Kleen et al., 2012; Vezzani et al., 2011) 
